Search

GlaxoSmithKline PLC

Cerrado

SectorSanidad

1,753.5 0.83

Resumen

Variación precio

24h

Actual

Mínimo

1739

Máximo

1770.5

Métricas clave

By Trading Economics

Ingresos

-1.4B

435M

Ventas

780M

8.4B

P/B

Media del Sector

14.907

47.946

BPA

0.51

Rentabilidad por dividendo

3.82

Margen de beneficios

5.173

Empleados

66,841

EBITDA

-153M

2.6B

Recomendaciones

By TipRanks

Recomendaciones

Neutral

Estimación a 12 Meses

+21.94% upside

Dividendos

By Acuity

Rentabilidad por dividendo

Media del Sector

3.82%

2.27%

Próximas Ganancias

28 oct 2026

Fecha Próximo Dividendo

7 ene 2027

Próxima Fecha de Ex Dividendo

12 nov 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

-8.1B

70B

Apertura anterior

1752.67

Cierre anterior

1753.5

Noticias sobre sentimiento de mercado

By Acuity

57%

43%

261 / 340 Clasificación en Healthcare

GlaxoSmithKline PLC Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

9 oct 2026, 23:50 UTC

News

Constellation Brands Inc shares are modestly higher in after-market trading as analysts assess the company's valuation amid its focus on beer, wine, and spirits.

9 oct 2026, 23:25 UTC

News

Aon PLC declared a quarterly dividend of $0.820 per share, payable on November 13, 2026, and confirmed third-quarter earnings release for October 28, 2026.

9 oct 2026, 23:15 UTC

News

PayPal Holdings Inc is trading lower in after-hours activity, focusing on expanding credit offerings and Buy Now Pay Later services while planning share buybacks.

9 oct 2026, 23:15 UTC

News

Coca-Cola Consolidated Inc. declared a quarterly dividend of $0.25 per share, payable on November 6, 2026, to shareholders on record as of October 23, 2026.

9 oct 2026, 23:10 UTC

News

EnerSys receives a strong buy designation from Wall Street analysts, driven by optimism about AI infrastructure's impact on the data center sector.

9 oct 2026, 23:05 UTC

News

Truist Financial announces a $250K grant to support Gulf Coast communities' relief and recovery efforts ahead of Hurricane Isaias.

9 oct 2026, 23:05 UTC

News

JP Morgan reaffirms Overweight rating on Parker-Hannifin Corp, lowering its price target to $1.13K in a report released after the market closed.

9 oct 2026, 23:05 UTC

News

DICK'S Sporting Goods faces two class action lawsuits alleging securities fraud related to its business performance and disappointing financial results.

9 oct 2026, 23:01 UTC

News

Royal Caribbean Cruises Ltd is trading modestly lower in after-market hours, continuing a downward trend despite analysts suggesting the stock may be undervalued.

9 oct 2026, 23:01 UTC

Social Media
News

Perrigo Company PLC is reportedly under renewed takeover interest from an unidentified buyer, with speculation that CVC Capital may pursue an acquisition.

9 oct 2026, 23:01 UTC

News

Delta Air Lines Inc cut its guidance after missing third-quarter earnings and revenue estimates, with shares trading modestly lower in after-market hours.

9 oct 2026, 23:01 UTC

News
Social Media

Verizon shares are trading higher in after-market hours, despite reports of its worst trading day since 2002 amid competitive pressures from SPCX and T-Mobile's decline.

9 oct 2026, 22:50 UTC

News
Social Media

Star Bulk Carriers announces a partnership with Hermes World Maritime and renews equity offerings with Deutsche Bank for $41.37M and Jefferies for $75M.

9 oct 2026, 22:50 UTC

News

GoDaddy faces a class action lawsuit from Pomerantz LLP alleging securities fraud and unlawful business practices, encouraging affected shareholders to join by October 20, 2026.

9 oct 2026, 22:21 UTC

News

CareTrust REIT, Inc. released its sixth annual Corporate Sustainability Report, highlighting advancements in sustainability initiatives and adherence to ISS ESG Prime status.

9 oct 2026, 22:20 UTC

News

Mesa Laboratories Inc announced a quarterly dividend of $0.16 per share, payable on December 15, 2026, to shareholders of record on November 30, 2026.

9 oct 2026, 21:01 UTC

Correlated Moves
News

USD/PLN is gaining and remains above its 20-day moving average, near the upper end of its one-month range, despite earlier pulling back from a session high.

9 oct 2026, 20:41 UTC

News
Correlated Moves

USD/SEK is modestly higher, supported by an increase in the U.S. Baker Hughes total rig count to 603 from 598.

9 oct 2026, 20:40 UTC

News

Standard Motor Products announces CFO Nathan R. Iles' resignation effective October 30, 2026, with James J. Burke as interim CFO, prompting a decline in after-market trading.

9 oct 2026, 20:07 UTC

News

United Parcel Service Inc shares are higher, supported by plans to hire 100k seasonal workers and new services aimed at enhancing parcel security and pricing power.

9 oct 2026, 20:07 UTC

News
Correlated Moves
Social Media

Microsoft introduces its new AI model, Microsoft-Decision-1, which reportedly makes decisions 35 times faster than OpenAI's GPT-6 Sol, as announced by CEO Satya Nadella.

9 oct 2026, 20:07 UTC

News

Baird analyst Andrew Wittmann lowered Construction Partners Inc's price target to $115.00 from $141.00 while maintaining an Outperform rating.

9 oct 2026, 20:07 UTC

News

Barclays analyst Michael Lonegan lowers Idacorp's price target to $149.00 from $162.00 while maintaining an Overweight rating.

9 oct 2026, 20:07 UTC

Macro Event
News

Evercore ISI maintains its Underperform rating on Franklin Resources, lowering the price target to $35, contributing to a decline in the stock.

9 oct 2026, 20:07 UTC

Macro Event
News

Dollar General shares advanced, buoyed by broader market gains, despite earlier pulling back from a session high, amid a significant drop in consumer sentiment.

9 oct 2026, 20:07 UTC

News

UBS reaffirms Buy rating on Biogen Inc and raises price target to $270 from $240, while CCB International initiates coverage with an Outperform rating.

9 oct 2026, 20:07 UTC

Correlated Moves
News
Social Media

Viking Therapeutics is seeing increased interest amid reports of a potential bidding war, with speculation about suitors including LLY and positive momentum in the biotech sector.

9 oct 2026, 20:07 UTC

News

Schrodinger Inc rebounds amid volatility, supported by a $1.8 billion Biohub partnership announced by the White House focusing on AI-ready biological data.

9 oct 2026, 20:07 UTC

Social Media
News

Raymond James initiated coverage on Kymera Therapeutics Inc with an Outperform rating and set a price target of $140.

9 oct 2026, 20:07 UTC

Social Media
Event
News

Marvell Technology Inc. shares advanced after Stifel reiterated a Buy rating and raised its price target to $370, supported by increased fiscal year 2028 revenue guidance.

Comparación entre iguales

Cambio de precio

GlaxoSmithKline PLC previsión

Precio Objetivo

By TipRanks

21.94% repunte

Estimación a 12 Meses

Media 2,116.25 GBX  21.94%

Máximo 3,010 GBX

Mínimo 1,700 GBX

De acuerdo con 14 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para GlaxoSmithKline PLC Dist en los últimos 3 meses.

Consenso

By TipRanks

Neutral

14 ratings

3

Comprar

8

Mantener

3

Vender

Sentimiento

By Acuity

261 / 340 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Coyuntura bajista

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de GlaxoSmithKline PLC

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D. The company offers shingles, meningitis, respiratory syncytial virus, flu, polio, influenza, and pandemic vaccines. It also provides medicines for HIV, oncology, respiratory/immunology, and other specialty medicine products, as well as inhaled medicines for asthma and chronic obstructive pulmonary disease, and antibiotics for infections. It has a collaboration agreement with CureVac to develop mRNA-based influenza vaccines, and with Wave Life Sciences and Elsie Biotechnologies, Inc for oligonucleotide platform development; two strategic collaborations with Relation to advance therapeutics for fibrotic diseases and osteoarthritis; and multi-target strategic alliance with GSK to develop breakthrough treatments for people afflicted with Parkinson's disease; as well as collaboration with Flagship Pioneering to discover novel medicines and vaccines. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.dom.